Indian pharmaceutical majors are set to tap the generic anti-depressant market in the US, the largest pharma market in the world. The anti-depressant drug market in the US is primarily ruled by......
Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008. This increase is despite......
Lupin, the Mumbai-based drug company, and its US subsidiary, Lupin Pharmaceuticals, have mutually settled a patent violation case pending in a US court on the bacterial infection drug Omnicef,......